Induced Pluripotent Stem Cell (iPSC) Core

The Induced Pluripotent Stem Cell (iPSC) Core Facility at the Regenerative Medicine Institute (RMI) uses the latest techniques to reprogram, expand and characterize human iPS cells from human skin or blood tissues of healthy subjects and diseased patients. We then turn the iPS cells into specific cells of the human body, including components of the nervous system, eyes, blood, bones, heart, gut, liver and pancreas, for use by researchers. Some applications of this technology includes human “disease modeling-in-a-dish,” developing human reporter cell lines via genetic modification, drug screening on pathological human cell types and potentially developing cell replacement or regenerative therapies.

Internal Users - Please click HERE to access the internal iPSC Core web page